Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.63 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.63 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.63 |
| ▸ | CD69 | Q07108 | 1/20 | 0.53 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.48 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.48 |
| ▸ | AMY2A | P04746 | 2/20 | 0.48 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | FGF1 | P05230 | 1/20 | 0.47 |
| ▸ | FGF2 | P09038 | 1/20 | 0.47 |
| ▸ | VEGFA | P15692 | 1/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31701597 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL31701427 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL16360849 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL13747867 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL181379 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL16527289 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL19561594 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL15790585 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL22193218 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA | |
| SCHEMBL31700500 | 1.00 | LGALS3 (0.63) | LGALS3LGALS8LGALS4CD69CHIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180161350-A1 | TERNARY MIXTURES OF 6'-SL, LNnT and LST c | GLYCOM A/S (DK) | 2018-06-14 | — | — | US | disclosed |
| US-20180163185-A1 | MUTATED SIALIDASES | GLYCOM A/S (DK) | 2018-06-14 | — | — | US | disclosed |
| US-9963729-B2 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2018-05-08 | — | — | US | disclosed |
| US-20160289721-A1 | DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2016-10-06 | — | — | US | disclosed |
| US-9382564-B2 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2016-07-05 | — | — | US | disclosed |
| US-9234225-B2 | Method for generating human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2016-01-12 | — | — | US | disclosed |
| US-20150239923-A1 | SYNTHESIS OF A TETRASACCHARIDE CONTAINING N-ACETYLLACTOSAMINE | GLYCOM A/S (DK) | 2015-08-27 | — | — | US | disclosed |
| US-8993740-B2 | Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine | GLYCOM A/S (DK) | 2015-03-31 | — | — | US | disclosed |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
| US-20140212930-A1 | DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-07-31 | — | — | US | disclosed |
| US-20120309949-A1 | METHOD FOR PREPARATION OF THE TETRASACCHARIDE LACTO-N-NEOTETRAOSE (LNNT) CONTAINING N-ACETYLLACTOSAMINE | GLYCOM A/S (DK) | 2012-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235850-A1 | SYNTHESIS OF HMO CORE STRUCTURES | GNE, OGT, GALE | LGALS3 165/4885LGALS8 134/4885LGALS4 127/4885 |
| US-20180163185-A1 | MUTATED SIALIDASES | NEU4, NEU2, NEU1 | LGALS3 499/4885LGALS8 400/4885LGALS4 410/4885 |
| US-20120309949-A1 | METHOD FOR PREPARATION OF THE TETRASACCHARIDE LACTO-N-NEOTETRAOSE (LNNT) CONTAINING N-ACETYLLACTOSAMINE | B3GNT2, NANS, FUT5 | LGALS3 112/4885LGALS8 126/4885LGALS4 145/4885 |
| US-20180161350-A1 | TERNARY MIXTURES OF 6'-SL, LNnT and LST c | ST6GAL1, GALNT6, FUT6 | LGALS3 78/4885LGALS8 63/4885LGALS4 106/4885 |
| US-20150239923-A1 | SYNTHESIS OF A TETRASACCHARIDE CONTAINING N-ACETYLLACTOSAMINE | FUT6, B3GNT2, FUT5 | LGALS3 352/4885LGALS8 294/4885LGALS4 221/4885 |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | LCT, B4GALT1, GALNT1 | LGALS3 193/4885LGALS8 176/4885LGALS4 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.